Marigold (Calendula officinalis L.): An evidence-based systematic review by the natural standard research collaboration

Journal of Herbal Pharmacotherapy

Volumn 6, Issue 3-4, 2006, Pages 135-159

  Basch, Ethan ^a   Bent, Steve ^a   Foppa, Ivo ^b   Haskmi, Sadaf ^c   Kroll, David ^d   Mele, Michelle ^e   Szapary, Philippe ^f   Ulbricht, Catherine ^g   Vora, Mamta ^e   Yong, Sophanna ^h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d DUKE UNIVERSITY   (United States)

^e NORTHEASTERN UNIVERSITY   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

Calendula officinalis L.; Death flower; Marigold; Scotch marigold; Summer's bride

Indexed keywords

ACONITUM MOLDAVICUM EXTRACT; ALPHA TOCOPHEROL; AMOXICILLIN; ANESTHETIC AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ARNICA MONTANA EXTRACT; ECHINACEA PURPUREA EXTRACT; FLAVONOID; GARLIC EXTRACT; HERBACEOUS AGENT; HEXOBARBITAL; HYPERICUM PERFORATUM EXTRACT; HYPOCHOLESTEROLEMIC AGENT; INDOMETACIN; INSULIN; LAVENDER OIL; MARIGOLD EXTRACT; NHED; OTIKON OTIC; PETROLATUM; PLACEBO; PLANT EXTRACT; SAPONIN DERIVATIVE; SCORZONERA HUMILIS EXTRACT; SEDATIVE AGENT; TRIETHANOLAMINE SALICYLATE; TRITERPENOID; UNCLASSIFIED DRUG; VERBASCUM THAPSUS EXTRACT; XANTHOPHYLL;

ABSENCE OF SIDE EFFECTS; ACONITUM MOLDAVICUM; ALTERNATIVE MEDICINE; ANAPHYLACTIC SHOCK; ANTIBACTERIAL ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIVIRAL ACTIVITY; ATOPIC DERMATITIS; BREAST CANCER; CANCER RADIOTHERAPY; CLINICAL TRIAL; CYTOTOXICITY; DOSE RESPONSE; DRUG ABSORPTION; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG ISOLATION; DRUG MEGADOSE; DRUG POTENTIATION; DRUG SAFETY; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; GENOTOXICITY; HUMAN; INFORMATION RETRIEVAL; LD 50; MARIGOLD; MEDICINAL PLANT; META ANALYSIS; MONOTHERAPY; NONHUMAN; OPTIMAL DRUG DOSE; OTITIS MEDIA; PATIENT COMPLIANCE; PHARMACODYNAMICS; POSTMARKETING SURVEILLANCE; PRIMARY PREVENTION; PRIORITY JOURNAL; RADIATION DERMATITIS; RECOMMENDED DRUG DOSE; REVIEW; RISK BENEFIT ANALYSIS; SCORZONERA HUMILIS; SKIN CANCER; SKIN INFECTION; SKIN INJURY; SKIN TOXICITY; SUNBURN; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VERBASCUM THAPSUS; WOUND HEALING;

ANIMALS; CALENDULA; CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EVIDENCE-BASED MEDICINE; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 33947106647     PISSN: 15228940     EISSN: 15229106     Source Type: Journal    
DOI: 10.1300/J157v06n03_08     Document Type: Review

References (50)

1. Hamburger M, Adler S, Baumann D, et al. Preparative purification of die major anti-inflammatory triterpenoid esters from Marigold (Calendula officinalis). Fitoterapia 2003;74(4):328-338.
2. Cordova CA, Siqueira IR, Netto CA, et al. Protective properties of butanolic extract of the Calendula officinalis L. (marigold) against lipid peroxidation of rat liver microsomes and action as free radical scavenger. Redox Rep 2002;7(2):95-102.
3. Chaparzadeh N, D'Amico ML, Khavari-Nejad RA, et al. Antioxidative responses of Calendula officinalis under salinity conditions. Plant Physiol Biochem 2004;42(9): 695-701.
4. Chakurski I, Matev M, Stefanov G, et al. [Treatment of duodenal ulcers and gastroduodenitis with a herbal combination of Symphitum officinalis and Calendula officinalis with and without antacids]. Vutr Boles 1981;20(6):44-47.
5. Chakurski I, Matev M, Koichev A, et al. [Treatment of chronic colitis with an herbal combination of Taraxacum officinale, Hipericum perforatum, Melissa officinaliss, Calendula officinalis and Foeniculum vulgare]. Vutr Boles 1981; 20(6): 51-54.
6. Marinchev VN, Bychkova LN, Balvanovich NV, et al. [Use of calendula for therapy of chronic inflammatory diseases of eyelids and conjunctiva]. Oftal' mologicheskii Zhurnal 1971;26(3):196-198.
7. Mozherenkov VP, Shubina LF. [Treatment of chronic conjunctivitis with Calendula]. Med Sestra 1976;35(4):33-34.
8. Krazhan IA, Garazha NN. [Treatment of chronic catarrhal gingivitis with polysorb-immobilized calendula]. Stomatologiia (Mosk) 2001;80(5):11-13.
9. Bogdanova NS, Nikolaeva IS, Shcherbakova LI, et al. [Study of anti-viral properties of Calendula officinalis]. Farmakol Toksikol 1970;33(3):349-355.
10. Corina P, Dimitris S, Emanuil T, et al. [Treatment with acyclovir combined with a new Romanian product from plants]. Oftalmologia 1999;46(1):55-57.
11. Barbour EK, Sagherian V, Talhouk S, et al. Evaluation of homeopathy in broiler chickens exposed to live viral vaccines and administered Calendula officinalis extract. Med Sci Monit 2004;10(8):BR281-BR285.
12. Matev M, Chakurski I, Stefanov G, et al. [Use of an herbal combination with laxative action on duodenal peptic ulcer and gastroduodenitis patients with a concomitant obstipation syndrome]. Vutr Boles 1981;20(6):48-51.
13. Iauk L, Lo Bue AM, Milazzo I, et al. Antibacterial activity of medicinal plant extracts against periodontopathic bacteria. Phytother Res 2003; 17(6):599-604.
14. Neto JJ, Fracasso JF, Neves MDCLC, et al. Treatment of varicose ulcer and skin lesions with calendula. Revista de Ciencias Farm Sao Paulo 1996;17:181-186.
15. Anonymous. Final report on the safety assessment of Calendula officinalis extract and Calendula officinalis. Int J Toxicol 2001;20 Suppl 2:13-20.
16. Sarrell EM, Mandelberg A, Cohen HA. Efficacy of naturopathic extracts in the management of ear pain associated with acute otitis media. Arch Pediatr Adolesc Med 2001;155(7):796-799.
17. Sarrell EM, Cohen HA, Kahan E. Naturopathic treatment for ear pain in children. Pediatrics 2003; 111(5 Pt 1):e574-e579.
18. Quetin-Leclercq J, Elias R, Balansard G, et al. Cytotoxic activity of some triterpenoid saponins. Planta Med 1992;58(3):279-281.
19. Ramos A, Edreira A, Vizoso A, et al. Genotoxicity of an extract of Calendula officinalis L. J Ethnopharmacol 1998;61(1):49-55.
20. Dietz V. Calendula preparations to treat cutaneous infections. Alt Med Alert 1998;1(12):140-142.
21. Bruynzeel DP, van Ketel WG, Young E, et al. Contact sensitization by alternative topical medicaments containing plant extracts. The Dutch Contact Dermatoses Group. Contact Dermatitis 1992;27(4):278-279.
22. Reider N, Komericki P, Hausen BM, et al. The seamy side of natural medicines: Contact sensitization to arnica (Arnica montana L.) and marigold (Calendula officinalis L.). Contact Dermatitis 2001;45(5):269-272.
23. Wintzen M, Donker AS, Van Zuuren EJ. Recalcitrant atopic dermatitis due to allergy to Compositae. Contact Dermatitis 2003;48(2):87-88.
24. Shipochliev T. [Uterotonic action of extracts from a group of medicinal plants]. Vet Med Nauki 1981;18(4):94-98.
25. Brinker F. Herb Contraindications and Drug Interactions. Sandy: Eclectic Medical Publications, 1998: 46.
26. Bojadjiev C. On the sedative and hypotensive effect of preparations from the plant Calendula officinalis. Nauch Trud Visshi Med Inst Sof 1964;43:15-20.
27. Samochowiec L. Pharmacological study of saponosides from Aralia mandshurica Rupr. et Maxim and Calendula officinalis L. Herba Pol 1983;29:151-155.
28. Yoshikawa M, Murakami T, Kishi A, et al. Medicinal flowers. III. Marigold. (1): Hypoglycemic, gastric emptying inhibitory, and gastroprotective principles and new oleanane-type triterpene oligoglycosides, calendasaponins A, B, C, and D, from Egyptian Calendula officinalis. Chem Pharm Bull (Tokyo) 2001;49(7):863-870.
29. Vidal-Ollivier E, Elias R, Faure F, et al. Flavonol glycosides from Calendula officinalis flowers. Planta Med 1989;55:73-74.
30. Neukirch H, D'Ambrosio M, Dalla VJ, et al. Simultaneous quantitative determination of eight triterpenoid monoesters from flowers of 10 varieties of Calendula officinalis L. and characterisation of a new triterpenoid monoester. Phytochem Anal 2004;15(1):30-35.
31. Marukami T, Kishi A, Yoshikawa M. Medicinal flowers. IV. Marigold. (2): Structures of new ionone and sesquiterpene glycosides from Egyptian Calendula officinalis. Chem Pharm Bull (Tokyo) 2001;49(8):974-978.
32. Qiu X, Reed DW, Hong H, et al. Identification and analysis of a gene from Calendula officinalis encoding a fatty acid conjugase. Plant Physiol 2001; 125(2): 847-855.
33. Della Loggia R., et al. Topical anti-inflammatory activity of Calendula officinalis extracts. Planta Med 1990;56:658.
34. Della LR, Tubaro A, Sosa S, et al. The role of triterpenoids in the topical anti-inflammatory activity of Calendula officinalis flowers. Planta Med 1994;60(6):516-520.
35. Zitterl-Eglseer K, Sosa S, Jurenitsch J, et al. Anti-oedematous activities of the main triterpendiol esters of marigold (Calendula officinalis L.). J Ethnopharmacol 1997;57(2):139-144.
36. Bezakova L, Masterova I, Paulikova I, et al. Inhibitory activity of isorhamnetin glycosides from Calendula officinalis L. on the activity of lipoxygenase. Pharmazie 1996;51(2):126-127.
37. Rao S, Udupa A, Udupa SL, et al. Calendula and Hypericum: Two homeopathic drugs promoting wound healing in rats. Fitoterapia 1991;62(6):508-510.
38. Klouchek-Popova E, Popov A, Pavlova N, et al. Influence of the physiological regeneration and epithelialization using fractions isolated from Calendula officinalis. Acta Physiol Pharmacol Bulg 1982;8(4):63-67.
39. Kalvatchev Z, Walder R, Garzaro D. Anti-HIV activity of extracts from Calendula officinalis flowers. Biomed Pharmacother 1997;51(4):176-180.
40. De Tommasi N, Conti C, Stein ML, et al. Structure and in vitro antiviral activity of triterpenoid saponins from Calendula arvensis. Planta Med 1991;57(3):250-253.
41. Dumenil G, Chemli R, Balansard C, et al. [Evaluation of antibacterial properties of marigold flowers (Calendula officinalis L.) and other homeopathic tinctures of C. officinalis L. and C. arvensis L. (author's transl)]. Ann Pharm Fr 1980;38(6):493-499.
42. Modesto A, Lima KC, de Uzeda M. Effects of three different infant dentifrices on biofilms and oral microorganisms. J Clin Pediatr Dent 2000;24(3):237-243.
43. Gracza L. Oxygen-containing terpene derivatives from Calendula officinalis. Planta Med 1987;53:227.
44. Chew BP, Wong MW, Wong TS. Effects of lutein from marigold extract on immunity and growth of mammary tumors in mice. Anticancer Res 1996;16(6B): 3689-3694.
45. Elias R, De Meo M, Vidal-Ollivier E, et al. Antimutagenic activity of some saponins isolated from Calendula officinalis L., C. arvensis L. and Hedera helix L. Mutagenesis 1990;5(4):327-331.
46. Amirghofran Z, Azadbakht M, Karimi MH. Evaluation of the immunomodulatory effects of five herbal plants. J Ethnopharmacol 2000;72(1-2): 167-172.
47. Marchenko MM, Kopyl'chuk HP, Hrygor'ieva OV. [Activity of cytoplasmic proteinases from rat liver in Heren's carcinoma during tumor growth and treatment with medicinal herbs]. Ukr Biokhim Zh 2000;72(3):91-94.
48. Pommier P, Gomez F, Sunyach MP, et al. Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol 2004;22(8):1447-1453.
49. Shaparenko BA, Slivko AB, Bazarova OV, et al. On use of medicinal plants for treatment of patients with chronic suppurative otitis. Zh Ushn Gorl Bolezn 1979;39: 48-51.
50. Lievre M, Marichy J, Baux S, et al. Controlled study of three ointments for the local management of 2nd and 3rd degree burns. Clin Trials Meta-Analysis 1992;28: 9-12.